IRIS
Zambelli, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.361
EU - Europa 689
AS - Asia 395
AF - Africa 143
OC - Oceania 13
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.355
SG - Singapore 192
FI - Finlandia 187
CN - Cina 146
NG - Nigeria 143
IE - Irlanda 126
DE - Germania 93
FR - Francia 68
IT - Italia 59
GB - Regno Unito 53
NL - Olanda 31
IN - India 30
SE - Svezia 22
RU - Federazione Russa 14
AU - Australia 13
HK - Hong Kong 8
CL - Cile 7
CZ - Repubblica Ceca 7
JP - Giappone 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BE - Belgio 5
CA - Canada 5
ES - Italia 4
BR - Brasile 3
PL - Polonia 3
TW - Taiwan 3
BG - Bulgaria 2
CH - Svizzera 2
KR - Corea 2
MD - Moldavia 2
NO - Norvegia 2
RO - Romania 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
QA - Qatar 1
SI - Slovenia 1
TH - Thailandia 1
Totale 2.619
Salva come PNG Salva come JPEG
Città #
Chandler 218
Helsinki 187
New York 161
Benin City 143
Singapore 140
Dublin 126
Shanghai 121
Lawrence 114
Princeton 114
Ashburn 95
Wilmington 76
Boardman 63
Paris 57
London 35
Amsterdam 29
San Mateo 29
Ann Arbor 16
Fairfield 15
Leawood 13
Los Angeles 13
Milan 12
Phoenix 11
Seattle 10
Florence 8
Mumbai 8
Woodbridge 8
Pune 7
Evanston 6
Moscow 6
Norwalk 6
Santa Clara 6
Brno 5
Brussels 5
Cincinnati 5
Falkenstein 5
Heidelberg 5
Bergamo 4
Berlin 4
Bologna 4
Frankfurt am Main 4
Hanover 4
Munich 4
Novokuznetsk 4
Barcelona 3
Cupertino 3
Darang 3
Gunzenhausen 3
Melbourne 3
Nuremberg 3
Rome 3
São Paulo 3
Taipei 3
Tampa 3
Ahmedabad 2
Barnaul 2
Bradford 2
Cambridge 2
Casoria 2
Chennai 2
Chester 2
Chisinau 2
Clearwater 2
Denver 2
Glasgow 2
Grafton 2
Guangzhou 2
Gwangju 2
Hangzhou 2
Hooversville 2
La Canada Flintridge 2
Napoli 2
Navi Mumbai 2
Röllbach 2
Saint Louis 2
San Diego 2
Sha Tin Wai 2
Shenzhen 2
Shinjuku 2
Trieste 2
Villeneuve-le-Roi 2
Warrensburg 2
Warwick 2
Washington 2
Xi'an 2
Aberdeen 1
Alexandria 1
Amman 1
Athens 1
Belovo 1
Bitola 1
Boston 1
Brisbane 1
Buenos Aires 1
Central 1
Davis 1
Dearborn 1
Den Haag 1
Doha 1
Esfahan 1
Fort Worth 1
Totale 2.014
Salva come PNG Salva come JPEG
Nome #
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants 98
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 59
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 58
ACUTE UPPER GASTROINTESTINAL BLEEDING (AUGB) IN ITALY: AN INTERIM ANALYSIS OF THE ORGANIZATIONAL ASPECTS CARING AN EVOLVING DISEASE 50
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 49
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 48
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 45
TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY 40
PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY 38
OUTPATIENT MANAGEMENT OF PATIENTS WITH GLASGOW-BLATCHFORD BLEEDING SCORE LOW-RISK UPPER-GASTROINTESTINAL HEMORRHAGE: A MULTICENTER VALIDATION STUDY IN ITALY 37
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective. 37
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 37
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 36
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY 35
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 34
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis 34
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 34
Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling 33
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 32
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform 31
ONCO-i2b2: Improve Patients Selection through Case-Based Information Retrieval TechniquesData Integration in the Life Sciences 31
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen - A pilot study in patients with refractory malignancies 30
Remodelling of the Ca2+ signalling machinery in endothelial progenitor cells isolated from breast cancer patients 30
MORTALITY IN UPPER GASTROINTESTINAL BLEEDING IN ITALY: DATA FROM NATIONAL SURVEY 29
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128 29
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer 29
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 28
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971 28
Absence of the K303R estrogen receptor alpha mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment 28
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score 27
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe 27
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial 27
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8(+) subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence 26
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 26
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 25
An ICT infrastructure to integrate clinical and molecular data in oncology research 25
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy 25
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 23
COVID-19 Sequelae and the Host Pro-Inflammatory Response: An Analysis From the OnCovid Registry 23
Circulating CD33+large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+monocytes with their CD16+subset 23
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer 23
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy 23
Cellular and molecular determinants of all‐ trans retinoic acid sensitivity in breast cancer: Luminal phenotype and α expression 22
trattamento conservativo dell' osteonecrosi spontaea del ginocchio in fase iniziale con campi pulsati: studio a 2 anni di follow-up minimo 22
An epirubicin/paclitaxel combination mobilizes large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen 22
Clinical toxicity of cryopreserved circulating progenitor cells infusion 22
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression 22
Cellular and molecular determinants of breast cancer sensitivity to all-trans retinoic acid: Identification of a gene expression fingerprint predicting responsiveness 20
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective 20
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 20
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 19
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry 19
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 19
Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study 18
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast 18
Clinical Review on the Management of Breast Cancer Visceral Crisis 17
Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives 17
Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer 17
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives 16
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 16
Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation 16
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction 16
Erratum: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9 (31877-31887) DOI: 10.18632/oncotarget.25874) 15
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer 15
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies 15
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation 15
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC) 15
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 15
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 15
No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer 15
Prospective multicenter quality assessment of endotherapy of biliary stones: does center volume matter? 15
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 14
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma 14
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 14
Management and Survival of Pleural Mesothelioma: A Record Linkage Study 14
Trabectedin for the treatment of breast cancer 14
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 14
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 13
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer 13
Opportunities and Challenges of Synthetic Data Generation in Oncology 13
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2 13
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy 13
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients 13
Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results 13
Free mobility of medical oncologists across the European Union: still a false myth 13
Pulmonary function and complications following chemotherapy and stem cell support in breast cancer 13
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM) 13
Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC) 13
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 13
Promises and Challenges of Adult Stem Cells in Cancer Therapy 13
Targeting triple negative breast cancer: Is p53 the answer? 13
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry 13
Short commentaries on data published by Petit et al. on locoregional risk after lipofilling in breast cancer patients 13
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 13
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 12
Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy 12
STEM-CELL FACTOR AND INTERLEUKIN-6, ALONE OR IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, DO NOT AFFECT THE GROWTH OF SOLID TUMOR-CELL LINES 12
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study 12
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 12
Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer 12
Totale 2.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.867
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/2021135 0 1 2 0 6 40 12 14 28 17 3 12
2021/2022481 4 1 4 17 5 6 7 12 184 82 138 21
2022/20231.066 250 48 136 86 98 62 5 53 102 142 67 17
2023/20241.021 71 80 162 47 36 197 54 46 27 31 103 167
2024/2025105 43 7 12 20 23 0 0 0 0 0 0 0
Totale 2.809